Genital warts incidence and healthcare resource utilisation in Australia

Sexually Transmitted Infections

Volumn 86, Issue 3, 2010, Pages 181-186

  Pirotta, Marie ^a   Stein, Alicia N ^b   Conway, E Lynne ^b   Harrison, Christopher ^c   Britt, Helena ^c   Garland, Suzanne ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSL LIMITED   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; WART VIRUS VACCINE;

ABLATION THERAPY; ADULT; ARTICLE; AUSTRALIA; CONDYLOMA ACUMINATUM; CONSULTATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTICE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITAL COST; HOSPITALIZATION; HUMAN; IMMUNIZATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PODOPHYLLUM; PREVALENCE; PRIORITY JOURNAL; VACCINATION;

ADULT; AUSTRALIA; CONDYLOMATA ACUMINATA; FAMILY PRACTICE; FEMALE; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; YOUNG ADULT;

EID: 77953783767     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2009.040188     Document Type: Article

References (29)

1. Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009;199:805-14.
2. Grulich A, De Visser R, Smith A, et al. Sex in Australia: sexually transmissible infection and blood-borne virus history in a representative sample of adults. Aust N Z J Public Health 2003;27:234-41.
3. Dinh TH, Sternberg M, Dunne EF, et al. Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999-2004. Sex Transm Dis 2008;35:357-60.
4. Kjaer S, Tran T, Sparen P, et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007;196:1447-54.
5. Health Protection Agency. Trends in genital herpes and genital warts infections, United Kingdom: 1999 to 2008. Health Protection Report 2009;31:30.
6. Brotherton JM, Mullins RM. Estimating coverage of the national HPV vaccination program: where are we at? Med J Aust 2009;191:188.
7. Britt H, Miller G, eds. General practice in Australia, health priorities and policy 1998 to 2008. General practice series no. 24. Cat. no. GEP 24. Canberra: AIHW, 2009.
8. Classification Committee of the World Organization of Family Doctors (WICC). ICPC-2: international classification of primary care. 2nd edn. Oxford: Oxford University Press, 1998.
9. Anatomic Therapeutic Chemical (ATC) Classification, The WHO Collaborating Centre for Drug Statistics Methodology. 2007. http://www.whocc.no/atcddd/ (accessed Aug 2009).
10. Medicare Australia. Medicare benefits schedule (MBS) statistics reports. 2007. http://www.medicareaustralia.govau/providers/health-statistics/ statistical-reporting.htm (accessed Aug 2009).
11. Australian Bureau of Statistics. Australian bureau of statistics. Series B projections by age and sex. 2007. http://www.abs.govau/AUSSTATS/abs@.nsf/ DetailsPage/3222.02004%20to%202101?OpenDocument (accessed Aug 2009).
12. Stein A, Britt H, Harrison C, et al. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 2009:27:520-9.
13. Dept of Health and Ageing. 2009. http://www.health.govau/internet/ mbsonline/publishing.nsf/Content/Medicare-Benefits-Schedule-MBS-1 (accessed Aug 2009).
14. Dept of Health and Ageing. 2009 Medicare Statistics - March Quarter. 2009. http://www.health.govau/internet/main/publishing.nsf/Content/medstat- mar09-analysis-b (accessed Aug 2009).
15. MIMS Online. http://mims.hcn.netau/ifmx-nsapi/mims-data/?MIval=2MIMS- ssearch (accessed Aug 2009).
16. AIHW. Interactive national hospital data (data cubes). National Hospital Morbidity Database. Canberra, Australia: Australian Institute of Health and Welfare 2009. http://www.aihw.govau/hospitals/datacubes/index.cfm (accessed August 2009).
17. Australian Government. Australian refined diagnosis related groups definitions manual. Version 5.0. Canberra, Australia: Commonwealth Department of Health and Ageing, 2002.
18. Victoria - Public Hospitals and Mental Health Services. Policy and funding guidelines. Melbourne, Victoria, Australia: Metropolitan Health and Aged Care Services Division, Victorian Government 2008. http://www.health.vic.govau/ pfg/pfg0809/pfg0809.pdf (accessed July 2009).
19. Marra F, Ogilvie G, Colley L, et al. Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect 2009;85:111-15.
20. Microbiology and Epidemiology of STIs and HIV (MESH) Department. Selected STI diagnoses (numbers and rates) from GUM clinics in the UK: 2004-2008. Health Protection Agency 2009. http://www.hpa.orguk/web/HPAwebFile/HPAweb-C/ 1215589013442 (accessed Sep 2009).
21. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003;36:1397-403.
22. Woodhall SC, Jit M, Cai C, et al. Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom. Sex Transm Dis 2009;36:515-21.
23. Hoy T, Singhal P, Willey V, et al. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin 2009;25:2343-51.
24. Pirotta M, Stein A, Fairley C, et al. Patterns of treatment of external genital warts in Australian sexual health clinics. Sex Transm Dis 2009;36:376-9.
25. Langley P, White D, Drake S. Patterns of treatment and resourse utilization in the treatment of external genital warts in England and Wales. Int J STD AIDS 2004;15:473-8.
26. Freedman E, Britt H, Harrison CM, et al. Sexual health problems managed in Australian general practice: a national, cross sectional survey. Sex Transm Infect 2006;82:61-6.
27. Hillemanns P, Breugelmans JG, Gieseking F, et al. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. BMC Infect Dis 2008;8:76.
28. Pirotta M, Ung L, Stein A. The psychosocial burden of HPV-related disease and screening interventions. Sex Transm Infect. Published Online First: 24 August 2009. doi: 10.1136/sti.2009.037028.
29. Fairley CK, Hocking J, Chen MY, et al. Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women. Sex Transm Infect 2009;85:499-502.